Evidence map›Paper›PMID 27538868›Full record

Trial reportJournal of feline medicine and surgery2017

Maropitant administered orally 2-2.5 h prior to morphine and dexmedetomidine reduces the incidence of emesis in cats.

Manuel Martin-Flores, Alicia Mastrocco, Augusto M Lorenzutti, Luis Campoy, Pati Kirch, Marisa Stone, McKenzie M Learn, Jordyn M Boesch

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of feline medicine and surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. AAFP Feline Anesthesia Guidelines.Journal of feline medicine and surgery · 2018
    Guideline
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Spotlight on the perioperative use of maropitant citrate.Veterinary medicine (Auckland, N.Z.) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Manuel Martin-Flores1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Alicia Mastrocco1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Augusto M Lorenzutti2 Department of Pharmacology and Toxicology, Catholic University of Córdoba, Córdoba, Argentina.
Luis Campoy1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Pati Kirch1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Marisa Stone1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
McKenzie M Learn1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Jordyn M Boesch1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
New York State College of Veterinary Medicine · USCornell University · USUniversidad Católica de Córdoba · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives The main goal of this study was to test the antiemetic effects of maropitant administered orally 2-2.5 h prior to morphine and dexmedetomidine in cats. Methods Eighty-three healthy female cats were randomized to receive maropitant (8 mg orally; n = 39) or no treatment (control; n = 44), 2-2.5 h prior to morphine 0.1 mg/kg and dexmedetomidine 20 µg/kg intramuscularly. The incidence of sialorrhea, lip licking, retching and vomiting were recorded after morphine/dexmedetomidine injection. Results There were no differences between groups in terms of age or weight. The treated group received a mean ± SD dose of maropitant of 2.9 ± 0.6 mg/kg. The incidence of sialorrhea and lip licking was no different between groups. The incidence of retching (control 36% vs maropitant 13%; P = 0.012) and emesis (control 32% vs maropitant 13%; P = 0.03) was significantly reduced in cats treated with maropitant. Conclusions and relevance Maropitant 8 mg (total dose) administered orally 2-2.5 h prior to morphine and dexmedetomidine significantly reduced, but did not eliminate, the incidences of retching and vomiting. Maropitant did not decrease the occurrence of sialorrhea and lip licking, signs that may be indicative of nausea. Maropitant might be useful for morning administration to prevent emesis in outpatient cats requiring sedation or anesthesia; however, dose regimens or interval of administration might require improvement.

Indexed as

OvariectomyAdministration, OralAnalgesics, OpioidAnimalsAntiemeticsCat DiseasesCatsDexmedetomidineFemaleInjections, IntramuscularMorphinePostoperative Nausea and VomitingQuinuclidinesTreatment OutcomeAnalgesics, OpioidAntiemeticsDexmedetomidinemaropitantMorphineQuinuclidines

Identifiers

PMID27538868
PMCPMC11104116
OpenAlexW2515831360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.